AI-generated analysis. Always verify with the original filing.
vTv Therapeutics Inc. filed an 8-K on March 10, 2026, disclosing an Investor Presentation dated March 2026 as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' for purposes of Section 18 of the Exchange Act. Item 9.01 lists the exhibits including the presentation and cover page interactive data.
Event Type
Disclosure
Voluntary
Variant
8-K
(including Exhibit 99.1) shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities of, Section 18 of the Exchange Act, nor shal
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 vTv Therapeutics' Investor Presentation dated March 2026 104 Cover Page Interactive